2 adrenoceptor polymorphisms: Are they clinically important?

Thorax

Volumn 51, Issue 4, 1996, Pages 351-353

  Hall, I P ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; SALBUTAMOL; SALMETEROL; TERBUTALINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

AMINO ACID SEQUENCE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; EDITORIAL; GENETIC POLYMORPHISM; HUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; GENETICS; METABOLISM; MOLECULAR GENETICS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TACHYPHYLAXIS;

ADRENERGIC BETA-AGONISTS; AMINO ACID SEQUENCE; ASTHMA; HUMANS; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, ADRENERGIC, BETA-2; TACHYPHYLAXIS;

EID: 0029665825     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.51.4.351     Document Type: Editorial

References (0)